Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Savient Pharma introduces Krystexxa in US
The company claims that Krystexxa is now the first and only therapy available to address this unmet medical need. Savient Pharma CEO John Johnson said since receiving FDA
The company claims that Krystexxa is now the first and only therapy available to address this unmet medical need. Savient Pharma CEO John Johnson said since receiving FDA
NorLevo is an oral emergency contraceptive, which is taken within 72 hours after unprotected sexual intercourse or contraceptive failure to prevent unwanted pregnancy. Sosei has taken over the
Tranzyme Pharma’s Ulimorelin is indicated for the management of postoperative ileus (POI) in hospital and acute care settings. The companies are expecting to enroll about 300 bowel surgery
Covance Genomics Laboratory and Ingenuity will work together to develop new and novel approaches, using Ingenuity’s IPA software, to obtain more actionable insights from NGS data and to
Strive was designed to evaluate people with a mutation in the CF gene known as G551D. In the study, profound improvements in lung function (forced expiratory volume in
The Phase 3 trial was supported by the results from a cooperative group-sponsored Phase 2 clinical trial evaluating Nexavar in combination with capecitabine in patients with advanced breast
The agreement includes process development, scale-up and manufacturing for pre-clinical studies. OctoPlus evaluated the feasibility of a controlled release formulation that combines a proprietary eye care ingredient of
The trial, which began last month and is scheduled to finish in June 2011, aims to determine whether Antabuse can deplete the pool of residual virus that regular
In the study, consisting of 243 postmenopausal women, nitroglycerin cream demonstrated a capability to increase bone density by about 7% when applied daily to the upper arms for
TXA127 is a pharmaceutical grade formulation of a naturally occurring peptide known to stimulate early hematopoietic precursor cells in the bone marrow. Tarix Pharma expects to recruit a